195 related articles for article (PubMed ID: 21815491)
1. [A case of intraocular lymphoma having retinal adverse events associated with intravitreal methotrexate].
Kuroiwa N; Abematsu N; Matsuo Y; Nakao K; Sakamoto T
Nippon Ganka Gakkai Zasshi; 2011 Jul; 115(7):611-6. PubMed ID: 21815491
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
[TBL] [Abstract][Full Text] [Related]
3. An Asian patient with intraocular lymphoma treated by intravitreal methotrexate.
Wang JK; Yang CM; Lin CP; Shan YD; Lo AY; Tien HF
Jpn J Ophthalmol; 2006; 50(5):474-478. PubMed ID: 17013703
[TBL] [Abstract][Full Text] [Related]
4. Toxic corneal epitheliopathy after intravitreal methotrexate and its treatment with oral folic acid.
Gorovoy I; Prechanond T; Abia M; Afshar AR; Stewart JM
Cornea; 2013 Aug; 32(8):1171-3. PubMed ID: 23676783
[TBL] [Abstract][Full Text] [Related]
5. Two cases of primary intraocular lymphoma: fine needle aspiration diagnosis and intravitreal methotrexate treatment.
Zhao T; Li Y; Tang L; Wei X; Zhu X
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):142-144. PubMed ID: 21336740
[TBL] [Abstract][Full Text] [Related]
6. [Intravitreal chemotherapy for intraocular lymphoma].
Helbig H; Cerny T; de Smet MD
Ophthalmologe; 2003 Feb; 100(2):145-9. PubMed ID: 12589460
[TBL] [Abstract][Full Text] [Related]
7. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
Watanabe K; Arai A; Takase H; Takahashi H; Iwanaga Y; Sugamoto Y; Sugita S; Mochizuki M; Miura O
Rinsho Ketsueki; 2009 Mar; 50(3):182-6. PubMed ID: 19352085
[TBL] [Abstract][Full Text] [Related]
8. A case of primary intraocular lymphoma treated by intravitreal methotrexate.
Kim E; Kim C; Lee J; Cho Y
Korean J Ophthalmol; 2009 Sep; 23(3):210-4. PubMed ID: 19794951
[TBL] [Abstract][Full Text] [Related]
9. Unusual presentation of cornea verticillata with intravitreal methotrexate in a case of primary intraocular lymphoma.
Hasan N; Narde HK; Das AK; Chawla R
BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35027386
[TBL] [Abstract][Full Text] [Related]
10. Intraocular T-cell lymphoma due to mycosis fungoides and response to intravitreal methotrexate.
Reddy R; Kim SJ
Ocul Immunol Inflamm; 2011 Aug; 19(4):234-6. PubMed ID: 21770799
[TBL] [Abstract][Full Text] [Related]
11. Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.
Velez G; Boldt HC; Whitcup SM; Nussenblatt RB; Robinson MR
Ophthalmic Surg Lasers; 2002; 33(4):329-33. PubMed ID: 12134997
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma - 20 years of experience.
Habot-Wilner Z; Frenkel S; Pe'er J
Br J Haematol; 2021 Jul; 194(1):92-100. PubMed ID: 33900619
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.
Fishburne BC; Wilson DJ; Rosenbaum JT; Neuwelt EA
Arch Ophthalmol; 1997 Sep; 115(9):1152-6. PubMed ID: 9298056
[TBL] [Abstract][Full Text] [Related]
14. High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma.
Akiyama H; Takase H; Kubo F; Miki T; Yamamoto M; Tomita M; Mochizuki M; Miura O; Arai A
Cancer Sci; 2016 Oct; 107(10):1458-1464. PubMed ID: 27412324
[TBL] [Abstract][Full Text] [Related]
15. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.
Smith JR; Rosenbaum JT; Wilson DJ; Doolittle ND; Siegal T; Neuwelt EA; Pe'er J
Ophthalmology; 2002 Sep; 109(9):1709-16. PubMed ID: 12208721
[TBL] [Abstract][Full Text] [Related]
16. [Initial experience of treatment of primary intraocular lymphomas associated with primary CNS lymphomas].
Tropinskaia OF; Grishina EE; Serova NK; Kobiakov GL; Aronov MS; Shishkina LV
Zh Vopr Neirokhir Im N N Burdenko; 2012; 76(4):19-25; discussion 25. PubMed ID: 23033588
[TBL] [Abstract][Full Text] [Related]
17. Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients.
Zhou X; Zhou X; Shi H; Lai J; Wang Q; Li Y; Chen K; Li Q; Zhou Q; Cao X; Chen B; Xiao J
BMC Ophthalmol; 2020 May; 20(1):189. PubMed ID: 32397978
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma.
Velez G; Yuan P; Sung C; Tansey G; Reed GF; Chan CC; Nussenblatt RB; Robinson MR
Arch Ophthalmol; 2001 Oct; 119(10):1518-24. PubMed ID: 11594954
[TBL] [Abstract][Full Text] [Related]
19. [Malignant lymphoma of the central nervous system and eye].
Tropinskaia OF; Serova NK; Aronov MS; Kobiakov GL
Vestn Oftalmol; 2008; 124(1):14-9. PubMed ID: 18318202
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate.
Zhao H; Wang X; Mao Y; Peng X
BMC Ophthalmol; 2020 Jan; 20(1):10. PubMed ID: 31906917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
